144 related articles for article (PubMed ID: 2422470)
1. Cardiovascular actions of xamoterol (ICI 118,587) in anaesthetized cats, rats, and guinea pigs.
Mian MA; Malta E; Raper C
J Cardiovasc Pharmacol; 1986; 8(2):314-23. PubMed ID: 2422470
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
3. The in vitro pharmacology of xamoterol (ICI 118,587).
Malta E; Mian MA; Raper C
Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Hattori Y; Sakuma I; Nakao Y; Kanno M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenoceptor selectivity of dobutamine: in vivo and in vitro studies.
Maccarrone C; Malta E; Raper C
J Cardiovasc Pharmacol; 1984; 6(1):132-41. PubMed ID: 6199596
[TBL] [Abstract][Full Text] [Related]
6. Selective and full beta 1-adrenoceptor agonist action of a catechol derivative of denopamine (T-0509) in the guinea-pig cardiac muscle and trachea: comparison with denopamine, xamoterol and isoprenaline.
Yabana H; Watanabe H; Narita H; Nagao T
Br J Pharmacol; 1992 Jun; 106(2):335-41. PubMed ID: 1356559
[TBL] [Abstract][Full Text] [Related]
7. The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure.
Virk SJ; Anfilogoff NH; Lawson N; Sadler AM; Smith SJ; Nuttall A; Murray RG; Littler WA; Davies MK
Eur Heart J; 1989 Mar; 10(3):227-34. PubMed ID: 2565233
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic and metabolic effects of xamoterol in exercising dogs.
Fischer G; Schneider W; Grohs JG; Ehrendorfer S; Raberger G
Eur J Pharmacol; 1990 Feb; 177(1-2):19-27. PubMed ID: 2140326
[TBL] [Abstract][Full Text] [Related]
9. Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.
Tangø M; Carlsen JE; Trap-Jensen J
Eur J Clin Pharmacol; 1985; 29(2):155-8. PubMed ID: 2866963
[TBL] [Abstract][Full Text] [Related]
10. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.
Hashimoto T; Shiina A; Toyo-Oka T; Hosoda S; Kondo K
Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751
[TBL] [Abstract][Full Text] [Related]
11. Myocardial, coronary, and peripheral effects of xamoterol (ICI 118,587) in open-chest pigs.
Galiè N; Metalli M; Zannoli R; Binetti G; Branzi A; Magnani B
Cardiovasc Drugs Ther; 1989 Mar; 3(1):91-7. PubMed ID: 2577281
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the beta 1-adrenoceptor stimulatory effects of the partial beta 1-agonists acebutolol, xamoterol, H142/08 and H201/70.
Abrahamsson T
Eur J Pharmacol; 1989 May; 164(1):121-8. PubMed ID: 2568935
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of xamoterol and isoprenaline on rat cardiac beta-adrenoceptors: studies of function and regulation.
Kowalski MT; Haworth D; Lu X; Thomson DS; Barnett DB
Br J Pharmacol; 1990 Jan; 99(1):27-30. PubMed ID: 2158836
[TBL] [Abstract][Full Text] [Related]
14. Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.
Baker JG; Kemp P; March J; Fretwell L; Hill SJ; Gardiner SM
FASEB J; 2011 Dec; 25(12):4486-97. PubMed ID: 21865315
[TBL] [Abstract][Full Text] [Related]
15. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
Silke B; Hanratty CG; Riddell JG
J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
[TBL] [Abstract][Full Text] [Related]
16. Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction.
Molajo AO; Bennett DH
Br Heart J; 1985 Jul; 54(1):17-21. PubMed ID: 2861834
[TBL] [Abstract][Full Text] [Related]
17. The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.
Nuttall A; Snow HM
Br J Pharmacol; 1982 Oct; 77(2):381-8. PubMed ID: 6128041
[TBL] [Abstract][Full Text] [Related]
18. The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats.
Parratt JR; Wadsworth RM
Br J Pharmacol; 1970 May; 38(3):554-71. PubMed ID: 4392541
[TBL] [Abstract][Full Text] [Related]
19. The partial agonist activity of xamoterol (ICI 118,587) studied by heart rate response in pithed rats.
Hashimoto T; Kondo K; Shiina A; Toyo-Oka T; Kawasaki K; Kimura K; Hosoda S
Jpn Circ J; 1988 Jan; 52(1):60-5. PubMed ID: 2896255
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the autonomic control of the failing heart.
Snow HM
Basic Res Cardiol; 1989; 84 Suppl 1():163-76. PubMed ID: 2573339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
